Ann Meulemans
Direttore/Membro del Consiglio presso Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen
Profilo
Ann Meulemans is the founder of OCTIMET Oncology NV, which was founded in 2016.
Currently, she is the Director at Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen since 2020.
In the past, she worked as Vice President at Movetis NV from 2007 to 2009.
Dr. Meulemans has a graduate and doctorate degree from the University of Antwerp.
Posizioni attive di Ann Meulemans
| Società | Posizione | Inizio |
|---|---|---|
Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen
 Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen Miscellaneous Commercial ServicesCommercial Services Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen operates as an organization for scientific research. The private company is based in Brussels, Belgium. | Direttore/Membro del Consiglio | 15/05/2020 |
Precedenti posizioni note di Ann Meulemans
| Società | Posizione | Fine |
|---|---|---|
OCTIMET Oncology NV
 OCTIMET Oncology NV BiotechnologyHealth Technology OCTIMET Oncology NV develops MET kinase inhibitors for the treatment of cancer. The company was founded by Timothy Perera, Ann Louise Meulemans, Paolo Comoglio, and Philip Owen in 2016 and is headquartered in Beerse, the Netherlands. | Fondatore | - |
Movetis NV
 Movetis NV Pharmaceuticals: GenericHealth Technology Movetis NV operates as a pharmaceutical company, that focuses on the discovery, development, and commercialization of drugs for the treatment of diseases in the gastrointestinal (GI) area. Its products address GI disorders, such as severe chronic constipation, ascites, and paediatric reflux, as well as severe forms of GI motility disorders, including refractory gastro-oesophageal reflux disease. The company was founded in November 2006 and is headquartered in Turnhout, Belgium. | Corporate Officer/Principal | - |
Formazione di Ann Meulemans
| University of Antwerp | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Movetis NV
Movetis NV Pharmaceuticals: GenericHealth Technology Movetis NV operates as a pharmaceutical company, that focuses on the discovery, development, and commercialization of drugs for the treatment of diseases in the gastrointestinal (GI) area. Its products address GI disorders, such as severe chronic constipation, ascites, and paediatric reflux, as well as severe forms of GI motility disorders, including refractory gastro-oesophageal reflux disease. The company was founded in November 2006 and is headquartered in Turnhout, Belgium. | Health Technology |
OCTIMET Oncology NV
OCTIMET Oncology NV BiotechnologyHealth Technology OCTIMET Oncology NV develops MET kinase inhibitors for the treatment of cancer. The company was founded by Timothy Perera, Ann Louise Meulemans, Paolo Comoglio, and Philip Owen in 2016 and is headquartered in Beerse, the Netherlands. | Health Technology |
Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen
Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen Miscellaneous Commercial ServicesCommercial Services Fonds Voor Wetenschappelijk Onderzoek - Vlaanderen operates as an organization for scientific research. The private company is based in Brussels, Belgium. | Commercial Services |
- Borsa valori
- Insiders
- Ann Meulemans
